Open AccessRecent Advances in Stroke Prevention in Patients with Atrial Fibrillation and End-Stage Renal Disease
Author(s) -
Federico Ronco,
Patrizio Mazzone,
Leila Hosseinian,
Simonetta Genovesi
Publication year - 2017
Publication title -
cardiorenal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.661
H-Index - 21
eISSN - 1664-3828
pISSN - 1664-5502
DOI - 10.1159/000470856
Subject(s) - medicine , stroke (engine) , atrial fibrillation , kidney disease , end stage renal disease , population , renal function , apixaban , cardiology , hemodialysis , rivaroxaban , warfarin , mechanical engineering , engineering , environmental health
Chronic kidney disease (CKD) is associated with a high prevalence of atrial fibrillation (AF), but in this population the risk/benefit ratio of anticoagulant therapy with vitamin K antagonists (VKA) for thromboprophylaxis is uncertain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom